Small molecule therapeutics that aid in clearing abnormal protein deposits observed in neurodegenerative diseases.
Nanoparticles for potent encapsulation and delivery of therapeutic molecules for prenatal fetal therapy in the amniotic sac
Synthetic oligonucleotides blocking natural degradation of utrophin to treat muscular dystrophy.
Human anti-ADAMTS13 antibodies cloned from patients with acquired thrombotic thromobocytopenia purpura (TTP) for use in targeted therapies, and generation of animal models that recapitulate pathologic features of TPP.
A novel treatment for rare disease Friedreich ataxia using p38 or MK2 kinase inhibitors
New compounds identified through high throughput screening which improve mitochondrial function of Friedreich ataxia cells.